| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $7.47B | +10.5% |
| Cost of Revenue | $5.28B | +8.6% |
| Gross Profit | $2.20B | +15.5% |
| R&D Expense | $167.0M | +50.5% |
| SG&A Expense | $1.27B | +11.2% |
| Operating Income | $607.0M | +16.7% |
| Pre-tax Income | -$457.0M | -306.8% |
| Income Tax | $70.0M | -33.3% |
| Net Income | -$527.0M |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $661.0M | -4.5% |
| Accounts Receivable | $1.07B | +4.9% |
| Inventory | $1.35B | +9.5% |
| Current Assets | $3.36B | +5.9% |
| Total Assets | $8.43B | +2.9% |
| Current Liabilities | $1.75B | -2.0% |
| Long-term Debt | $3.23B | +60.3% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$1.14B | -356.1% |
| Capital Expenditures | $116.0M | +45.0% |
| Investing Cash Flow | -$39.0M | +97.2% |
| Financing Cash Flow | $1.13B | +9.4% |
| Free Cash Flow | -$1.25B | -444.2% |
| -554.3% |
| EPS (Basic) | -$3.77 | -708.1% |
| EPS (Diluted) | -$3.77 | -718.0% |
| Total Liabilities |
| $5.52B |
| +12.8% |
| Stockholders' Equity | $2.92B | -11.8% |